FAQs
AntiParkinson Drugs Global Market Report 2023 – By Drugs Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAOB) Inhibitors, CatecholOMethyltransferase (COMT)inhibitors, Anticholinergics, Other Drugs), By Route of Administration (Oral, Injection, Transdermal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2023-2032
What is the definition of the anti-parkinson drugs market?
The anti-parkinson drugs market consists of sales of drugs used for treating Parkinson's disease (PD), generated by the establishments that manufacture these drugs. Parkinson's disease is a neurodegenerative disorder that affects predominately dopaminergic neurons in a specific area of the brain named substantia nigra and disturbs the movement of the body. People suffering from PD may experience tremor, bradykinesia, limb rigidity, gait, and balance problems. request a sample here
How will the anti-parkinson drugs market drivers and restraints affect anti-parkinson drugs market dynamics? What forces will shape the anti-parkinson drugs industry going forward?
The anti-parkinson drugs market growth is aided by increasing geriatric population and surging cases of parkinson's disease (PD). However, some anti-Parkinson drugs market restraints include increasing investments by governments and companies for parkinson’s disease drug R&D request a sample here
What is the forecast market size of the anti-parkinson drugs market?
The anti-parkinson drugs market forecast is expected to reach $7.78 billion in 2025 at a compound annual growth rate of 9%. request a sample here
How is the anti-parkinson drugs market segmented?
The global anti-Parkinson drugs market is segmented -
1) By Drugs Class: Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs .
2) By Route of Administration: Oral, Injection, Transdermal.
3) By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies.
request a sample here
Which region has largest share, and what is the market size and growth by geography according to the anti-parkinson drugs global market report?
For more detail on this, request a sample here.
Who are the key players of the global anti-parkinson drugs market?
Top competitors in the anti-parkinson drugs market are GlaxoSmithKline plc, Pfizer, Merck, Novartis, Roche, UCB S.A, Teva Pharmaceuticals, AbbVie Inc., Mylan, Boehringer Ingelheim, Orion Pharma, ACADIA Pharmaceuticals Inc, Sun Pharma, Wockhardt, Dr. Reddyrequest a sample here.
What are the key trends in the global anti-parkinson drugs market?
Major trends influencing the anti-parkinson drugs market include increasing investments by governments and companies for Parkinson’s disease drug R&D. request a sample here.
What are the major opportunities in the anti-parkinson drugs market and the approaches companies can take to take advantage of them?
For detail on the future and current opportunities in the global anti-parkinson drugs market, request a sample here.
How does the anti-parkinson drugs market relate to the overall economy and other similar markets?
request a sample here.
request a sample here.
request a sample here.
